药用玻璃包装市场规模、份额和成长分析（按材料、产品、药物类型和地区）：产业预测（2024-2031）

2022年全球药用玻璃包装市场规模为180亿美元，从2023年的199亿美元成长到2031年的417亿美元，复合年增长率预计将成长9.7%。

由于製药业的扩张以及消费者对非反应性和可回收玻璃的偏好，药用玻璃包装市场正在经历强劲成长。特别是在欧洲和西半球的已开发地区，为了实现永续的社会，玻璃的回收正在加速。随着领先的物流公司投资创新解决方案以提高竞争力，技术进步正在塑造市场。同时，随着製药公司努力减少废弃物和碳排放，向环保包装的转变正在加速。玻璃瓶完全可回收，是最环保的选择。在印刷和标籤技术进步的推动下，客製化和个人化的兴起进一步凸显了该市场不断发展的动态。

目录

介绍

• 分析目的
• 市场范围
• 定义

分析方法

• 资讯采购
• 次要/主要资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 市场概况及展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及前景

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特分析与影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考虑因素

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场魅力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 案例研究
• 专利分析
• 贸易分析

全球药用玻璃包装市场规模与复合年增长率：依材料分类（2024-2031）

• 市场概况
• Ⅰ型
• II型
• Ⅲ型

全球药用玻璃包装市场规模及复合年增长率：依产品分类（2024-2031）

• 市场概况
• 管瓶
  • 管瓶
  • 大管瓶
• 瓶子
• 药筒和注射器
• 安瓿

全球药用玻璃包装市场规模及复合年增长率：按药物类型划分（2024-2031）

• 市场概况
• 学名药
• 品牌药
• 生技药品

全球药用玻璃包装市场规模及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要企业采取的策略
• 近期市场趋势
• 主要企业市场占有率（2023年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• 格雷斯海默股份公司（德国）
• 康宁公司（美国）
• 尼普罗株式会社（日本）
• SGD SA (SGD Pharma)（法国）
• Stolzle-Oberglas GmbH（CAG Holding GmbH）（奥地利）
• Bormioli Pharma SpA（义大利）
• 西方製药服务公司（美国）
• 肖特股份公司（德国）
• 山东药用玻璃股份有限公司 (中国)
• 比森·克拉克（英国）
• 阿拉伯药用玻璃公司（埃及）
• 皮拉马尔玻璃私人有限公司（皮拉马尔集团）（印度）
• Sisecam 集团（土耳其）
• 维拉利亚（法国）
• 山东药维药用玻璃有限公司 (中国)
• 浙江华创药用玻璃有限公司 (中国)
• 常州华兴药用玻璃有限公司 (中国)
• 江苏华兴药用玻璃有限公司 (中国)
• 江苏凯迪药用玻璃有限公司 (中国)
• 江苏益康药用玻璃有限公司 (中国)

结论和建议

Global Pharmaceutical Glass Packaging Market size was valued at USD 18 billion in 2022 and is poised to grow from USD 19.9 billion in 2023 to USD 41.7 billion by 2031, growing at a CAGR of 9.7% during the forecast period (2024-2031).

The pharmaceutical glass packaging market is experiencing robust growth driven by the expanding pharmaceutical sector and a consumer preference for glass due to its non-reactivity and recyclability. Glass recycling initiatives are escalating, especially in developed regions of Europe and the western hemisphere, spurred by a collective push for sustainable practices. Technological advancements are reshaping the market as major logistics companies invest in innovative solutions to enhance competitiveness. Meanwhile, the industry's shift towards eco-friendly packaging is accelerating as pharmaceutical companies strive to minimize waste and their carbon footprint. Glass jars stand out as the most environmentally friendly option, being completely recyclable. The rise in customization and personalization, fueled by advancements in printing and labeling technologies, further underscores the evolving dynamics in this market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Glass Packaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Glass Packaging Market Segmental Analysis

Global Pharmaceutical Glass Packaging Market is segmented by Material, Product, Drug Type and Region. Based on Material, the market is segmented into Type I, Type II, Type, III. Based on Product, the market is segmented into Vials, Bottles, Cartridges and Syringes, Ampoules. Based on Drug Type, the market is segmented into Generic, Branded, Biologic. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Glass Packaging Market

The increasing utilization of biologics, such as monoclonal antibodies and vaccines, is a significant catalyst for the growth of the global pharmaceutical glass packaging market. As the need for biologics rises, the demand for secure, sterile, and high-quality packaging intensifies, emphasizing the importance of glass vials and syringes in the healthcare industry. The effectiveness of these biologics relies on the integrity of their packaging, thus driving the market for pharmaceutical glass packaging further. This trend highlights the crucial role that glass packaging plays in the safe and efficient delivery of biologic therapies, ultimately boosting market expansion and development opportunities.

Restraints in the Global Pharmaceutical Glass Packaging Market

One of the significant challenges facing the global pharmaceutical glass packaging market is the increasing preference for alternative packaging materials, such as plastic and metal. These alternatives are often more affordable, lighter, and offer greater flexibility, making them appealing options for pharmaceutical companies seeking cost-effective solutions. As these materials continue to gain traction due to their practical advantages, they pose a notable restraint to the glass packaging sector. This shift in preference could potentially hinder the growth of the glass packaging market, as manufacturers and suppliers are compelled to adapt to changing demands and explore innovative packaging solutions.

Market Trends of the Global Pharmaceutical Glass Packaging Market

The Global Pharmaceutical Glass Packaging market is witnessing a significant trend driven by the surging demand for biologic drug packaging. As biologics, such as vaccines and monoclonal antibodies, gain prominence in therapeutics, the necessity for specialized glass packaging solutions is intensifying. Glass vials and syringes are becoming indispensable for ensuring a sterile and stable environment crucial for preserving the efficacy of these sensitive drugs. This shift towards advanced packaging solutions is fostering innovation in material design and manufacturing processes, thereby propelling market growth, catering to the stringent requirements of the pharmaceutical industry and enhancing patient safety.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Patent Analysis
• Trade Analysis

Pharmaceutical Glass Packaging Market Size by Material & CAGR (2024-2031)

• Market Overview
• Type I
• Type II
• Type III

Pharmaceutical Glass Packaging Market Size by Product & CAGR (2024-2031)

• Market Overview
• Vials
  • Small Vials
  • Large Vials
• Bottles
• Cartridges and Syringes
• Ampoules

Pharmaceutical Glass Packaging Market Size by Drug Type & CAGR (2024-2031)

• Market Overview
• Generic
• Branded
• Biologic

Pharmaceutical Glass Packaging Market Size & CAGR (2024-2031)

• North America (Material, Product, Drug Type)
  • US
  • Canada
• Europe (Material, Product, Drug Type)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Material, Product, Drug Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Material, Product, Drug Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material, Product, Drug Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGD SA (SGD Pharma) (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stolzle-Oberglas GmbH (CAG Holding GmbH) (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bormioli Pharma S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schott AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Pharmaceutical Glass Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beatson Clark (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arab Pharmaceutical Glass Co. (Egypt)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Glass Private Limited (Piramal Group) (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sisecam Group (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verallia (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Yaowei Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhejiang Huachuang Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Changzhou Huaxing Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Huaxing Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Kaidi Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Yikang Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation